MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
132 hedge funds and large institutions have $474M invested in Merrimack Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 121 → 132 (+11)
Holders
132
Holding in Top 10
–
Calls
$5.42M
Puts
$3.35M
Top Buyers
| 1 | +$13.5M | |
| 2 | +$5.41M | |
| 3 | +$3.71M | |
| 4 |
Jane Street
New York
|
+$2.83M |
| 5 |
ACM
Alpha Capital Management
Austin,
Texas
|
+$2.4M |
Top Sellers
| 1 | -$35.3M | |
| 2 | -$5.58M | |
| 3 | -$4.79M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.45M |
| 5 |
Goldman Sachs
New York
|
-$3.06M |